These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37331129)

  • 1. Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering.
    Tribble JR; Hui F; Quintero H; El Hajji S; Bell K; Di Polo A; Williams PA
    Mol Aspects Med; 2023 Aug; 92():101193. PubMed ID: 37331129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration and Neuroprotection in Glaucoma.
    Gauthier AC; Liu J
    Yale J Biol Med; 2016 Mar; 89(1):73-9. PubMed ID: 27505018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targets of Neuroprotection in Glaucoma.
    He S; Stankowska DL; Ellis DZ; Krishnamoorthy RR; Yorio T
    J Ocul Pharmacol Ther; 2018; 34(1-2):85-106. PubMed ID: 28820649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
    Wilson AM; Di Polo A
    Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma].
    Jacobi A; van Zyl T
    Klin Monbl Augenheilkd; 2020 Feb; 237(2):133-139. PubMed ID: 32040976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells.
    Ju WK; Perkins GA; Kim KY; Bastola T; Choi WY; Choi SH
    Prog Retin Eye Res; 2023 Jul; 95():101136. PubMed ID: 36400670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucomatous optic neuropathy management: the role of neuroprotective agents.
    L Shahsuvaryan M
    Med Hypothesis Discov Innov Ophthalmol; 2013; 2(2):41-6. PubMed ID: 24600641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of potential novel glaucoma therapeutic options independent of intraocular pressure.
    Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ
    Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S1PR1 signaling attenuates apoptosis of retinal ganglion cells via modulation of cJun/Bim cascade and Bad phosphorylation in a mouse model of glaucoma.
    Basavarajappa D; Gupta V; Wall RV; Gupta V; Chitranshi N; Mirshahvaladi SSO; Palanivel V; You Y; Mirzaei M; Klistorner A; Graham SL
    FASEB J; 2023 Jan; 37(1):e22710. PubMed ID: 36520045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.
    Chang EE; Goldberg JL
    Ophthalmology; 2012 May; 119(5):979-86. PubMed ID: 22349567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational Pharmacology in Glaucoma Neuroprotection.
    Levin LA
    Handb Exp Pharmacol; 2017; 242():209-230. PubMed ID: 27752844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy Strategies for Glaucomatous Neurodegeneration.
    Lani-Louzada R; Dias MS; Linden R; Ribas VT; Petrs-Silva H
    Curr Gene Ther; 2021; 21(5):362-381. PubMed ID: 33573569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of retinal neuroprotective drugs for glaucoma].
    Liu XY; Sun XH
    Zhonghua Yan Ke Za Zhi; 2024 Oct; 60(10):860-869. PubMed ID: 39375145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.
    Al Hussein Al Awamlh S; Wareham LK; Risner ML; Calkins DJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update.
    Sim RH; Sirasanagandla SR; Das S; Teoh SL
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.